Home » Topics » Disease categories and therapies » Urology

Urology
RSS

TAS-303 shows potential as a novel therapeutic agent for stress urinary incontinence

Sep. 20, 2018

Sanofi achieves KEAP1/Nrf2 inhibition with bioavailable small molecules

Sep. 19, 2018

Patient recruitment starts in two phase II trials of DMX-200 in kidney disease

Sep. 18, 2018

Humanized midkine antibody demonstrates efficacy in experimental model of FSGS

Sep. 13, 2018

SuPAR predicts chronic kidney disease progression in Black Americans

Sep. 12, 2018

Daiichi Sankyo discovers bacterial tryptophanase inhibitors

Sep. 10, 2018

BAY-1101042, a potent NO- and heme-independent sGC activator suitable for oral dosing

Sep. 5, 2018

Janssen Pharmaceutica NV synthesizes 5-HT2B receptor antagonists

Sep. 4, 2018

Bristol-Myers Squibb patents receptor-interacting serine/threonine-protein kinase 1 inhibitors

Aug. 31, 2018

Positive topline data presented from phase Ib study of TAR-302 in idiopathic overactive bladder

Aug. 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...